Figure S1 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma

crossref(2023)

引用 0|浏览11
暂无评分
摘要

Figure S1 shows ASTX660 dose proportionality-power model analyses on AUC0-24 and Cmax by formulation.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要